Diagnostics to counteract antibiotic resistance

BioAmp Diagnostics is focused on addressing the critical issue of antibiotic resistance through the development of precision diagnostics. Their mission is to empower healthcare providers with timely and accurate information, enabling them to prescribe the appropriate antibiotic for infections right from the start. The company utilizes a unique chemistry-based approach that significantly reduces the time required to obtain diagnostic results, allowing for actionable insights in minutes rather than days. This rapid turnaround not only enhances patient care by facilitating quicker recovery but also supports evidence-based treatment practices and promotes the responsible use of antibiotics.

At the core of BioAmp's diagnostic capabilities is their proprietary DETECT technology, which stands for Dual-Enzyme Trigger-Enabled Cascade Technology. This innovative platform is initially being applied to the management of complicated urinary tract infections, providing healthcare professionals with the necessary data to make informed treatment decisions swiftly. By leveraging this advanced technology, BioAmp aims to revolutionize the way infections are diagnosed and treated, ultimately contributing to the global effort against antibiotic resistance.

United States

BioAmp Diagnostics is committed to preventing the misuse and overuse of antibiotics in healthcare through the development of innovative diagnostic tools, that will give medical providers the information they need to correctly treat an infection.

BioAmp Diagnostics

Company Details